Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Brixius-Anderko

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Biotechnology and Applied Biochemistry|February 26, 2016
An indole-deficient Escherichia coli strain improves screening of cytochromes P450 for biotechnological applicationsSimone Brixius-Anderko, Frank Hannemann, Michael Ringle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2023
Deciphering the Role of Fatty Acid-Metabolizing CYP4F11 in Lung Cancer and Its Potential As a Drug TargetHuiting Jia, Bjoern Brixius, Caleb Bocianoski, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2016
Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivationLina Schiffer, Anne-Rose Müller, Anna Hobler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2015
Metabolism of Oral Turinabol by Human Steroid Hormone-Synthesizing Cytochrome P450 EnzymesLina Schiffer, Simone Brixius-Anderko, Frank Hannemann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2025
Mycobacteriumabscessus CYP123 is a steroid hydroxylase with an implication in host infectionBjoern Brixius, Ozha Aziz, Audrey Shao, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 13, 2017
CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2Jana Malikova, Simone Brixius-Anderko, Sameer S Udhane, et al.
Biotechnology and Bioengineering|December 10, 2019
Identification and circumvention of bottlenecks in CYP21A2-mediated premedrol production using recombinant Escherichia coliLisa König, Simone Brixius-Anderko, Mohammed Milhim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2025
Functional studies on the cytochrome P450 splice variants CYP4F3A and CYP4F3B unveil the basis for their distinct physiological functionsBrisa Caroline Alves Chagas, Bjoern Brixius, Somayeh Pirhadi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 12, 2026
Cytochrome P450-mediated metabolism of K31, a Ko143-derived ATP-binding cassette subfamily G member 2 inhibitorFu-Ying Qin, Junjie Zhu, Bjoern Brixius, et al.
Hormone Research in Paediatrics|July 1, 2019
HIV Drug Efavirenz Inhibits CYP21A2 Activity with Possible Clinical ImplicationsJana Malikova, Tanja Zingg, Ralph Fingerhut, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biotechnology and Applied Biochemistry|February 26, 2016
An indole-deficient Escherichia coli strain improves screening of cytochromes P450 for biotechnological applicationsSimone Brixius-Anderko, Frank Hannemann, Michael Ringle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2023
Deciphering the Role of Fatty Acid-Metabolizing CYP4F11 in Lung Cancer and Its Potential As a Drug TargetHuiting Jia, Bjoern Brixius, Caleb Bocianoski, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2016
Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivationLina Schiffer, Anne-Rose Müller, Anna Hobler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2015
Metabolism of Oral Turinabol by Human Steroid Hormone-Synthesizing Cytochrome P450 EnzymesLina Schiffer, Simone Brixius-Anderko, Frank Hannemann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2025
Mycobacteriumabscessus CYP123 is a steroid hydroxylase with an implication in host infectionBjoern Brixius, Ozha Aziz, Audrey Shao, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 13, 2017
CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2Jana Malikova, Simone Brixius-Anderko, Sameer S Udhane, et al.
Biotechnology and Bioengineering|December 10, 2019
Identification and circumvention of bottlenecks in CYP21A2-mediated premedrol production using recombinant Escherichia coliLisa König, Simone Brixius-Anderko, Mohammed Milhim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2025
Functional studies on the cytochrome P450 splice variants CYP4F3A and CYP4F3B unveil the basis for their distinct physiological functionsBrisa Caroline Alves Chagas, Bjoern Brixius, Somayeh Pirhadi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 12, 2026
Cytochrome P450-mediated metabolism of K31, a Ko143-derived ATP-binding cassette subfamily G member 2 inhibitorFu-Ying Qin, Junjie Zhu, Bjoern Brixius, et al.
Hormone Research in Paediatrics|July 1, 2019
HIV Drug Efavirenz Inhibits CYP21A2 Activity with Possible Clinical ImplicationsJana Malikova, Tanja Zingg, Ralph Fingerhut, et al.
Pageof 3